DiaMedica Therapeutics Inc. (DMAC) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time DMAC price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 40.9 Neutral
Market Cap $368.0M
Volume 73.0K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-20.2M
EPS --
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Stahlberg Jan | 10% Owner | Buy | 1,061,277 | $7.19 | $7.6M | 2025 Nov 25 |
| Trill Ab | 10% Owner | Buy | 1,000,000 | $5.96 | $6.0M | 2025 Aug 27 |
| Jacinto Richard II | 10% Owner | Buy | 400,000 | $3.50 | $1.4M | 2025 Jul 23 |
| Trill Ab | 10% Owner | Buy | 1,542,857 | $3.50 | $5.4M | 2025 Jul 23 |
| TomEnterprise Private AB | 10% Owner | Buy | 2,857,142 | $3.50 | $10.0M | 2025 Jul 23 |
| Trill Ab | 10% Owner | Buy | 1,200,000 | $2.50 | $3.0M | 2024 Jun 28 |
| Von Koch Thomas | 10% Owner | Buy | 1,200,000 | $2.50 | $3.0M | 2024 Jun 28 |
| Wambeke David J. | Chief Business Officer | Buy | 20,000 | $2.46 | $49,200 | 2023 Nov 16 |
| TomEnterprise AB | 10% Owner | Buy | 1,470,588 | $3.40 | $5.0M | 2023 Jun 23 |
| Semba Charles Pauling | Director | Buy | 12,787 | $3.91 | $49,997 | 2023 Jun 23 |
| Pauls Dietrich John | President and CEO | Buy | 12,787 | $3.91 | $49,997 | 2023 Jun 23 |
| Pilnik Richard D. | Director | Buy | 38,363 | $3.91 | $149,999 | 2023 Jun 23 |
| Wambeke David J. | Chief Business Officer | Buy | 38,364 | $3.91 | $150,003 | 2023 Jun 23 |
| Giuffre Randall Michael | Director | Buy | 65,000 | $3.91 | $254,150 | 2023 Jun 23 |
| Kellen Scott | CFO and Secretary | Buy | 10,000 | $3.91 | $39,100 | 2023 Jun 23 |
| Wambeke David J. | Chief Business Officer | Buy | 468,750 | $1.60 | $750,000 | 2023 Apr 10 |
| Giuffre Randall Michael | Director | Buy | 57,079 | $1.42 | $81,023 | 2022 Dec 9 |
| Giuffre Randall Michael | Director | Buy | 24,874 | $1.40 | $34,709 | 2022 Dec 7 |
| Pilnik Richard D. | Director | Buy | 35,000 | $1.39 | $48,650 | 2022 Dec 5 |
| TomEqt Private AB | 10% Owner | Buy | 0 | $0.00 | $0 | 2022 Dec 2 |
Other Pharmaceutical Stocks
Take DMAC further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DMAC in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when DiaMedica Therapeutics Inc. next reports.
Set alerts on DMAC
Get notified when DiaMedica Therapeutics Inc. hits your price targets or technical conditions are met.
Get Started Free